Genmab is a dual listed company with shares traded on the Copenhagen stock exchange in Denmark and on NASDAQ Global Select Market in the US.

Analyst Coverage

Analyst Coverage

Firm Analyst Contact Information
ABG Sundal Collier
Viktor Sundberg
Emily Field
Bank of America/Merrill Lynch
Sachin Jain
Wimal Kapadia
Bryan, Garnier & Co
Victor Floc’h
Carnegie Bank
Jesper Ilsøe
Peter Verdult
Credit Suisse
Elizabeth Walton
Danske Markets Equities
Thomas Bowers
Rune Majlund Dahl
Goldman Sachs International
Keyur Parekh
Guggenheim Securities, LLC
Michael Schmidt, Ph.D.
Mattias Häggblom
H.C. Wainwright & Co.
Raghuram Selvaraju, Ph.D.
HSBC Bank Plc
Julie Mead
J.P. Morgan
James Gordon
Jefferies International Ltd.
Peter Welford
Jyske Bank
Henrik Hallengreen Laustsen
Kempen & Co
Suzanne van Voorthuizen
Morgan Stanley & Co. LLC
Matthew Harrison
Michael Novod
Michael Drøscher Jørgensen
RBC Capital Markets, LLC
Kennen MacKay, Ph.D.
Søren Løntoft Hansen
Carsten Lønborg Madsen
SVB Leerink
Jonathan Chang
Truist Securities
Asthika Goonewardene
Laura Sutcliffe

Genmab A/S is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

You are now leaving to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.